The Cooper Companies Stock - Analyst consensus ahead of next earnings

Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 02:10 CET. Details in the imprint.

The Cooper Companies (US2166481027) operates as a specialty healthcare group listed on Nasdaq under the ticker COO. With no major fresh corporate announcements on 06/20/2026, today’s focus shifts to analyst consensus and the company’s long-term business mix.

What consensus data signal

Publicly available aggregation sites show The Cooper Companies covered by a broad group of Wall Street analysts, with a mix of Buy and Hold ratings and a consensus target price above the recent mid-$60s trading band for COO shares.

The same data sets imply that the implied upside from current levels is moderate rather than extreme, reflecting a view that the stock is reasonably valued given its growth and margin profile.

Next earnings and expectations

Calendar overviews indicate that The Cooper Companies is expected to report its next quarterly numbers in roughly two and a half months, with some services counting around 75 days until the upcoming earnings call.

Into that event, the market will focus on organic revenue growth in both CooperVision and CooperSurgical, as well as on any updated commentary on integration, cost inflation and pricing power.

How the company makes money

The Cooper Companies generates most of its revenue from soft contact lenses through its CooperVision segment and from fertility and women’s health products in CooperSurgical, combining recurring consumables with medical devices and related services.

Where the stock trades today

The shares of The Cooper Companies (US2166481027) most recently closed on Nasdaq at $65.91 on 06/18/2026, based on public quote data for COO, with the next trading session set to provide the latest live price.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.